Boehringer’s Vargatef approved in the EU for lung cancer

… or locally recurrent non-small cell lung cancer (NSCLC) after first-line chemotherapy. Prof … lung cancer.” The launch of Giotrif/Gilotrif in 2013 as a treatment lung cancer … to make sizeable inroads into lung cancer. Vargatef, a triple angiokinase inhibitor …